Inc. (NYSE American: IBO), a company discovering and developing new offerings in human healthcare and wellness, today ...

Inc. (NYSE American: IBO), a company discovering and developing new offerings in human healthcare and wellness today ...

Fabtech Technologies, a pharmaceuticals engineering solutions provider, has filed for an IPO. The IPO will consist of a fresh ...

The Company has granted to the underwriters a 45-day option to purchase up to an additional 232,500 shares of common stock at the public offering price of $4.00 per share, less underwriting discounts ...

The gross proceeds from the offering, before deducting underwriting fees and other offering expenses payable by the Company, are expected to be $6.2 million. The offering is expected to close on or ...

Kairos Pharma, Ltd. ("Kairos Pharma" or the "Company") (NYSE American: KAPA), a clinical stage biopharmaceutical company developing cancer therapeutics ...

BKV Corporation (“BKV”) today announced that it has launched the initial public offering of 15,000,000 shares of its common stock. The underwriters will have a 30-day option to purchase an ...

Guardian Pharmacy Services, Inc. (“Guardian”) today announced the launch of its underwritten initial public offering of 6,750,000 shares of its Class A common stock pursuant to a registration ...

Kairos Pharma, Ltd. ("Kairos Pharma" or the "Company"), a clinical stage biopharmaceutical company developing cancer therapeutics designed to reverse cancer ...

In addition, Zenas has granted the underwriters a 30-day option to purchase up to an additional 1,985,294 shares of common stock at the initial public offering price, less underwriting discounts ...